MAPT and Alzheimer disease: In this study, no significant correlation was reported between in vivo PET and autoptic examination of tau deposits; therefore, the authors conclude that [18F]-AV-1451 may not be suited to detect tau aggregates in these non-AD tauopathies (Marquié et al., 2017).